Acute Porphyria Drug Database

Monograph

B01AD01 - Streptokinase
Not porphyrinogenic
NP

Rationale
Enzyme. No CYP-interactions.
Chemical description
Fibrinolytic enzyme given as infusion in coronary infarction and recent thrombosis.

Similar drugs
Explore alternative drugs in similar therapeutic classes B01A / B01AD or go back.

Tradenames and packages
From some sources, we get a list of packages (United Kingdom, Ireland, Estonia). Other sources contain more or less "clean" versions of the trade name (Denmark, Finland, Iceland, Lithuania, Norway). What you see here is the raw data we get from each country, so there will appear to be duplicates. The bold names are the searchable terms. The gray names that follow are all mapped to the bolded term.
Note: The cleaning is done automatically by a proprietary algorithm, and it may produce errors. We strive to improve it continuously.
United Kingdom
Biofactor Streptokinase · Biofactor Streptokinase 1.5million unit powder for solution for infusion vials · Biofactor Streptokinase 250,000unit powder for solution for infusion vials · Biofactor Streptokinase 750,000unit powder for solution for infusion vials · Streptase · Streptase 1.5million unit powder for solution for infusion vials · Streptase 250,000unit powder for solution for infusion vials · Streptase 750,000unit powder for solution for infusion vials · Streptokinase · Streptokinase 1.5million unit powder for solution for infusion vials · Streptokinase 250,000unit powder for solution for infusion vials · Streptokinase 750,000unit powder for solution for infusion vials
Norway
Streptokinase biofactor
Poland
Biostrepta · DISTREPTAZA
 
© NAPOS 2024
An unhandled error has occurred. Reload 🗙